Page 122 - Clinical Immunology_ Principles and Practice ( PDFDrive )

106 Part one Principles of Immune Response

4. Baldauf KJ, Royal JM, Hamorsky KT, et al. Cholera toxin B: one subunit 27. Caminschi I, Shortman K. Boosting antibody responses by targeting
with many pharmaceutical applications. Toxins (Basel) 2015;7:974–96. antigens to dendritic cells. Trends Immunol 2012;33:71–7.
5. Pierson TC, Graham BS. Zika Virus: Immunity and Vaccine Development. 28. McGreal EP, Miller JL, Gordon S. Ligand recognition by
Cell 2016;167:625–31. antigen-presenting cell C-type lectin receptors. Curr Opin Immunol
6. Sadanand S, Suscovich TJ, Alter G. Broadly Neutralizing Antibodies 2005;17:18–24.
Against HIV: New Insights to Inform Vaccine Design. Annu Rev Med 29. Lehmann CH, Heger L, Heidkamp GF, et al. Direct delivery of antigens to
2016;67:185–200. dendritic cells via antibodies specific for endocytic receptors as a
7. Ren H, Zhou P. Epitope-focused vaccine design against influenza A and B promising strategy for future therapies. Vaccines (Basel) 2016;4.
viruses. Curr Opin Immunol 2016;42:83–90. 30. Yuseff MI, Lennon-Dumenil AM. B Cells use Conserved Polarity Cues to
8. Cicala C, Nawaz F, Jelicic K, et al. HIV-1 gp120: A Target for Therapeutics Regulate Their Antigen Processing and Presentation Functions. Front
and Vaccine Design. Curr Drug Targets 2016;17:122–35. Immunol 2015;6:251.
9. Zarei AE, Almehdar HA, Redwan EM. Hib Vaccines: Past, Present, and 31. Avalos AM, Ploegh HL. Early BCR Events and Antigen Capture,
Future Perspectives. J Immunol Res 2016;2016:7203587. Processing, and Loading on MHC Class II on B Cells. Front Immunol
10. Baker CJ. Prevention of Meningococcal Infection in the United States: 2014;5:92.
Current Recommendations and Future Considerations. J Adolesc Health 32. Heesters BA, Myers RC, Carroll MC. Follicular dendritic cells: dynamic
2016;59:S29–37. antigen libraries. Nat Rev Immunol 2014;14:495–504.
11. Proft T, Fraser JD. Bacterial superantigens. Clin Exp Immunol 33. Duraes FV, Niven J, Dubrot J, et al. Macroautophagy in Endogenous
2003;133:299–306. Processing of Self- and Pathogen-Derived Antigens for MHC Class II
12. Sundberg EJ, Deng L, Mariuzza RA. TCR recognition of peptide/MHC Presentation. Front Immunol 2015;6:459.
class II complexes and superantigens. Semin Immunol 2007;19:262–71. 34. Kniepert A, Groettrup M. The unique functions of tissue-specific
13. Fraser JD, Proft T. The bacterial superantigen and superantigen-like proteasomes. Trends Biochem Sci 2014;39:17–24.
proteins. Immunol Rev 2008;225:226–43. 35. Sijts EJ, Kloetzel PM. The role of the proteasome in the generation of
14. Deshane J, Chaplin DD. Follicular dendritic cell makes environmental MHC class I ligands and immune responses. Cell Mol Life Sci
sense. Immunity 2010;33:2–4. 2011;68:1491–502.
15. Heesters BA, van der Poel CE, Das A, et al. Antigen Presentation to B 36. Shastri N, Nagarajan N, Lind KC, et al. Monitoring peptide processing for
Cells. Trends Immunol 2016;37:844–54. MHC class I molecules in the endoplasmic reticulum. Curr Opin
16. van Kasteren SI, Overkleeft H, Ovaa H, et al. Chemical biology of antigen Immunol 2014;26:123–7.
presentation by MHC molecules. Curr Opin Immunol 2014;26:21–31. 37. Schuette V, Burgdorf S. The ins-and-outs of endosomal antigens for
17. Blum JS, Wearsch PA, Cresswell P. Pathways of antigen processing. Annu cross-presentation. Curr Opin Immunol 2014;26:63–8.
Rev Immunol 2013;31:443–73. 38. Segura E, Amigorena S. Cross-Presentation in Mouse and Human
18. Unanue ER, Turk V, Neefjes J. Variations in MHC Class II Antigen Dendritic Cells. Adv Immunol 2015;127:1–31.
Processing and Presentation in Health and Disease. Annu Rev Immunol 39. Stern LJ, Santambrogio L. The melting pot of the MHC II peptidome.
2016;doi:10.1146/annurev-immunol-041015-055420. Curr Opin Immunol 2016;40:70–7.
19. Roche PA, Furuta K. The ins and outs of MHC class II-mediated antigen 40. Granados DP, Laumont CM, Thibault P, et al. The nature of self for T
processing and presentation. Nat Rev Immunol 2015;15:203–16. cells-a systems-level perspective. Curr Opin Immunol 2015;34:1–8.
20. Stumptner-Cuvelette P, Benaroch P. Multiple roles of the invariant chain 41. Appella E, Padlan EA, Hunt DF. Analysis of the structure of naturally
in MHC class II function. Biochim Biophys Acta 2002;1542:1–13. processed peptides bound by class I and class II major histocompatibility
21. ten Broeke T, Wubbolts R, Stoorvogel W. MHC class II antigen complex molecules. EXS 1995;73:105–19.
presentation by dendritic cells regulated through endosomal sorting. Cold 42. Starck SR, Shastri N. Non-conventional sources of peptides presented by
Spring Harb Perspect Biol 2013;5:a016873. MHC class I. Cell Mol Life Sci 2011;68:1471–9.
22. Denzin LK. Inhibition of HLA-DM Mediated MHC Class II Peptide 43. Hansen TH, Bouvier M. MHC class I antigen presentation: learning from
Loading by HLA-DO Promotes Self Tolerance. Front Immunol viral evasion strategies. Nat Rev Immunol 2009;9:503–13.
2013;4:465. 44. van de Weijer ML, Luteijn RD, Wiertz EJ. Viral immune evasion: Lessons
23. Mellins ED, Stern LJ. HLA-DM and HLA-DO, key regulators of MHC-II in MHC class I antigen presentation. Semin Immunol 2015;27:125–37.
processing and presentation. Curr Opin Immunol 2014;26:115–22. 45. Goldberg MF, Saini NK, Porcelli SA. Evasion of Innate and Adaptive
24. Pos W, Sethi DK, Wucherpfennig KW. Mechanisms of peptide repertoire Immunity by Mycobacterium tuberculosis. Microbiol Spectr 2014;2.
selection by HLA-DM. Trends Immunol 2013;34:495–501. 46. Leone P, Shin EC, Perosa F, et al. MHC class I antigen processing and
25. Sant AJ, Chaves FA, Leddon SA, et al. The control of the specificity of presenting machinery: organization, function, and defects in tumor cells.
CD4 T cell responses: thresholds, breakpoints, and ceilings. Front J Natl Cancer Inst 2013;105:1172–87.
Immunol 2013;4:340.
26. Schulze MS, Wucherpfennig KW. The mechanism of HLA-DM induced
peptide exchange in the MHC class II antigen presentation pathway. Curr
Opin Immunol 2012;24:105–11.